Hikma Pharmaceuticals (MEX:HIKN) FFO


MEX:HIKN Hikma Pharmaceuticals PLC MEX:HIKN
80 GF Score
Price MXN307.48
GF Value MXN426.22
! 5 Warning Signs
View Full Analysis

What is Hikma Pharmaceuticals FFO?

FFO (Funds from operations) only applies to REITs.

MEX:HIKN
80GF Score
Hikma Pharmaceuticals PLC MEX:HIKN
FFO is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Hikma Pharmaceuticals (MEX:HIKN) Overvalued in 2026?

Based on GuruFocus' analysis, Hikma Pharmaceuticals stock appears to be undervalued. The current stock price of MXN307.48 is trading 27.9% below its estimated GF Value™ of MXN426.22.

Key valuation signals for MEX:HIKN:

  • FFO:
  • GF Value™: MXN426.22 vs. price of MXN307.48 (27.9% below fair value)
  • GF Score™: 80/100 with 5 warning signs

No single metric tells the full story. See the MEX:HIKN stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Hikma Pharmaceuticals Business Description

Address 10 Portman Square, London, GBR, W1H 6AZ
Hikma Pharmaceuticals PLC is engaged in developing, manufacturing, and marketing a broad range of generic, branded, and in-licensed pharmaceutical products. The firm operates in three segments: injectables, Rx, and branded. The majority of the company's revenue is generated from its injectables segment, which supplies hospitals across markets with generic injectable products, supported by its manufacturing facilities. Geographically, North America is the company's key revenue-generating market, followed by the Middle East and North Africa, the United Kingdom, Europe, and the rest of the world.
80GF Score

Get the complete analysis for MEX:HIKN

FFO is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

MXN307.48
Price
MXN426.22
GF Value